Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer

Adrien Costantini, Jennifer Corny, Vincent Fallet, Sophie Renet, Sylvie Friard, Christos Chouaid, Boris Duchemann, Etienne Giroux-Leprieur, Laurent Taillade, Ludovic Doucet, Marina Nguenang, Stéphane Jouveshomme, Marie Wislez, Jean Tredaniel, Jacques Cadranel
ERJ Open Research 2018 4: 00120-2017; DOI: 10.1183/23120541.00120-2017

Article Information

vol. 4 no. 2
DOI 
https://doi.org/10.1183/23120541.00120-2017
Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received October 2, 2017
  • Accepted February 22, 2018
  • Published online April 20, 2018.
Copyright & Usage 
Copyright ©ERS 2018 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. Adrien Costantini1,
  2. Jennifer Corny2,
  3. Vincent Fallet1,
  4. Sophie Renet2,
  5. Sylvie Friard3,
  6. Christos Chouaid4,
  7. Boris Duchemann5,
  8. Etienne Giroux-Leprieur6,
  9. Laurent Taillade7,
  10. Ludovic Doucet8,
  11. Marina Nguenang9,
  12. Stéphane Jouveshomme2,
  13. Marie Wislez1,
  14. Jean Tredaniel2 and
  15. Jacques Cadranel1
  1. 1Assistance Publique-Hôpitaux de Paris, Hôpital Tenon and GRC-04 Theranoscan, Paris, France
  2. 2Hôpital Saint-Joseph, Paris, France
  3. 3Hôpital Foch, Suresnes, France
  4. 4Centre Hospitalier Intercommunal de Créteil, Créteil, France
  5. 5Hôpital Avicenne, Bobigny, France
  6. 6Hôpital Ambroise Pare, Boulogne-Billancourt, France
  7. 7Hôpital Pitié-Salpêtrière, Paris, France
  8. 8Hôpital Saint-Louis, Paris, France
  9. 9Hôpital Bichat and Université Paris-Diderot, Paris, France
  1. Jacques Cadranel, Hôpital Tenon, 4 Rue de la Chine 75970, Paris, France. E-mail: jacques.cadranel{at}aphp.fr
View Full Text

Article usage

Article usage: April 2018 to October 2022

AbstractFullPdf
Apr 2018029359
May 2018124257
Jun 2018012932
Jul 2018012828
Aug 2018010413
Sep 2018016930
Oct 2018023019
Nov 2018026939
Dec 2018024437
Jan 2019221525
Feb 2019321123
Mar 2019215128
Apr 2019121239
May 2019214927
Jun 2019118229
Jul 2019017724
Aug 2019018719
Sep 2019018514
Oct 2019215722
Nov 2019315216
Dec 2019013618
Jan 2020212210
Feb 2020310715
Mar 2020110217
Apr 202017417
May 202018614
Jun 20201348
Jul 202014410
Aug 20201229
Sep 202015423
Oct 202036218
Nov 20200758
Dec 20200654
Jan 2021112121
Feb 202147610
Mar 202108115
Apr 202113310
May 202127313
Jun 20210507
Jul 202124614
Aug 20211348
Sep 202129424
Oct 202114023
Nov 202112818
Dec 20211476
Jan 202204215
Feb 20220476
Mar 202202115
Apr 202203714
May 202213213
Jun 20220438
Jul 20220367
Aug 202204210
Sep 202215318
Oct 2022122026

Altmetrics

Back to top
Email
Print
Citation Tools
Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer
Adrien Costantini, Jennifer Corny, Vincent Fallet, Sophie Renet, Sylvie Friard, Christos Chouaid, Boris Duchemann, Etienne Giroux-Leprieur, Laurent Taillade, Ludovic Doucet, Marina Nguenang, Stéphane Jouveshomme, Marie Wislez, Jean Tredaniel, Jacques Cadranel
ERJ Open Research Apr 2018, 4 (2) 00120-2017; DOI: 10.1183/23120541.00120-2017
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

Subjects